大健康國際(02211.HK)年度收益10.89億元 同比減少16.0%
格隆匯9月25日丨大健康國際(02211.HK)公吿,截至2024年6月30日止年度全年業績,集團錄得收益人民幣10.89億元,同比減少16.0%;公司擁有人應占收益為人民幣40萬元(2023年:虧損為人民幣1.05億元)。每股盈利為人民幣0.06分(2023年:每股虧損為人民幣18.07分)。公司擁有人應占虧損減少,主要由於集團通過採取措施加強對各種經營成本控制,以提高公司盈利能力並改善公司未來的經營現金流,從而提高經營效率。
年度,集團已關閉多家虧損零售店,以儘量減少經營虧損。原先受惠於疫情防治的解除,實體門店的客流量本應逐漸增多,但受國家新政策影響,效果不似預期。集團積極打造品牌效應及開發新的營銷策略,以保持集團的銷售量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.